A phosphoproteomic signature in endothelial cells predicts vascular toxicity of tyrosine kinase inhibitors used in CML.

Blood Adv
Authors
Keywords
Year of Publication
2018
Journal
Blood Adv
Volume
2
Issue
14
Pages
1680-1684
Date Published
2018 07 24
ISSN
2473-9537
DOI
10.1182/bloodadvances.2018020396
PubMed ID
30021779
PubMed Central ID
PMC6058230
Links
Grant list
U54 HG008097 / HG / NHGRI NIH HHS / United States